Completed PHASE3 INTERVENTIONAL 2-arm NCT01551810

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (IVV)

The Phase Ⅲ Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

Sponsor: Hebei Center for Disease Control and Prevention

Conditions Influenza

Interventions Influenza Virus Vaccine Influenza Virus Vaccine(contains Preservative)

Updated 9 times since 2017 Last updated: Oct 8, 2023 Started: Mar 31, 2012 Primary completion: May 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Influenza and is currently completed. Hebei Center for Disease Control and Prevention leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Nov 2023 — Jul 2024 [monthly]

Completed PHASE3
Oct 2023 — Nov 2023 [monthly]

Completed PHASE3
Dec 2022 — Oct 2023 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hebei Center for Disease Control and Prevention
Institute of Medical Biology, Chinese Academy of Medical Sciences

Data source: Institute of Medical Biology, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shijiazhuang, China